Use of Genomic Information to Predict Treatment Response in Multiple Myeloma Patients By Computational Mapping of Protein Network Disturbances

Background: Multiple myeloma (MM) is an incurable heterogeneous hematological malignancy in which immune suppression and complex biology affect the disease and its response to treatment.

Blood Journal 2016